← brief for 2026-08-21 · Slowing decline

Letter to the Editor: Enhancing renin-angiotensin-aldosterone system inhibitors utilization through patiromer adherence - real-world insights for nephrology practice.

Article B Peer reviewed Small trial

Key takeaways

A study of 13447 patients with kidney disease found that using better-quality mineralocorticoid receptor antagonists (MRAs) could increase the use of triple therapy: an ACE inhibitor, an ARB and a mineralocorticoid receptor antagonist. This could help prevent kidney failure.

Who did this work

Feyissa GD

Source

Article · PubMed, the drug frontier · 2026 Sep 25
https://pubmed.ncbi.nlm.nih.gov/42626019/